Racial and Ethnic Disparities Found in Delivery of TAVR

An analysis raises the question of whether blacks and Hispanics are underrepresented in transcatheter aortic valve replacement.

The introduction of new effective technologies calls for efforts to ensure equitable access to them. Transcatheter aortic valve replacement (TAVR) has been shown to improve outcomes of patients with aortic stenosis, but little is known about whether it is available to all patients. Investigators used the Society of Thoracic Surgeons/American College of Cardiology TVT Registry to determine the racial/ethnic makeup of TAVR patients in the U.S. and to explore the association between race and outcomes.

Of the 70,221 patients (age, >65) treated at 455 sites from 2012 to 2016, 91% were non-Hispanic whites, 4% were non-Hispanic blacks, and 3% were Hispanic. These rates underrepresented nonwhites compared with their share of the U.S. population and …

Reviewing Author

Harlan M. Krumholz, MD, SM

Disclosures

Consultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime

EquityHugo Health; Refactor Health; Element Science

Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association

Harlan M. Krumholz, MD, SM

Disclosures

Consultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime

EquityHugo Health; Refactor Health; Element Science

Racial and Ethnic Disparities Found in Delivery of TAVR

Topics

Reviewing Author